Abstract:Introduction. Urinary C-peptide creatinine ratio (UCPCR) is used as a marker of endogenous insulin secretion. This study aims to assess the effectiveness of UCPCR for distinguishing between type 1 diabetes (T1DM) and non-T1DM (monogenic diabetes and T2DM) and predicting therapeutic choices in type 2 diabetes (T2DM) patients. Methods. Twenty-three patients with genetically confirmed monogenic diabetes (median age 35.0 years (interquartile range 30.0-47.0), 13 (56.5%) men), 56 patients with T1DM (median age 46.0 years (interquartile range 26.5-59.5), 28 (50.0%) men), 136 patients with T2DM (median age 53.0 years (interquartile range 42.0-60.0), 87 (64.0%) men), and 59 healthy subjects (median age 36.0 years (30.0-42.0), 26 (44.1%) men) were included. UCPCR was collected in the morning. Receiver operating characteristic (ROC) curves were used to identify optimal UCPCR cut-off values to differentiate T1DM from non-T1DM. This UCPCR cut-off was used to divide T2DM patients into two groups, and the two groups were compared. Results. The UCPCR was lower in patients with T1DM compared with T2DM, monogenic diabetes, and healthy subjects, while the UCPCR was similar in T2DM and monogenic diabetes. A UCPCR cut-off of ≥0.21 nmol/mmol distinguished between monogenic diabetes and T1DM (area under the curve [AUC], 0.949) with 87% sensitivity and 93% specificity. UCPCR≥0.20 nmol/mmol had 82% sensitivity and 93% specificity for distinguishing between T2DM and T1DM, with an AUC of 0.932. UCPCR was not reliable for distinguishing between monogenic diabetes and T2DM (AUC, 0.605). Twenty-five of 136 (18.4%) T2DM patients had UCPCR≤0.20 nmol/mmol. Compared with T2DM patients with a UCPCR>0.20 nmol/mmol, T2DM patients with UCPCR≤0.20 nmol/mmol had a lower serum C-peptide (fasting C-peptide, 0.39 nmol/L vs. 0.66 nmol/L, P<0.001; postprandial C-peptide, 0.93 nmol/L vs. 1.55 nmol/L, P<0.001), lower BMI (22.8 kg/m2 vs. 25.2 kg/m2, P=0.006), and higher percentage of insulin or secretagogue therapy (92.0% vs. 59.5%, P=0.002). Conclusions. UCPCR is a practical and noninvasive marker that can distinguish between TIDM and T2DM or monogenic diabetes. UCPCR≤0.20 nmol/mmol reflects severe impaired beta cell function and the need for insulin or secretagogue therapy in T2DM patients.

Urinary C-Peptide Creatinine Ratio As a Non-Invasive Tool for Identifying Latent Autoimmune Diabetes in Adults (LADA)

Clinical Implications of Urinary C-Peptide Creatinine Ratio in Patients with Different Types of Diabetes

Urinary C-peptide/creatinine Ratio: A Useful Biomarker of Insulin Resistance and Refined Classification of Type 2 Diabetes Mellitus

Utility of Fasting C-Peptide for the Diagnostic Differentiation of Patients with Type 1, Type 2 Diabetes, MODY, and LADA

Clinical clues for screening latent autoimmune diabetes from adults patients with type 2 diabetic mellitus

Development and validation of a clinical score for identifying patients with high risk of latent autoimmune adult diabetes (LADA): The LADA primary care-protocol study

Application of urine C-peptide creatinine ratio in type 2 diabetic patients with different levels of renal function

The Efficacy of 4 Islet Autoantibodies in the Diagnosis of Latent Autoimmune Diabetes in Adults

Insulin Autoantibody Could Help to Screen Latent Autoimmune Diabetes in Adults in Phenotypic Type 2 Diabetes Mellitus in Chinese

Distinct Secretion Pattern of Serum Proinsulin in Different Types of Diabetes

Diagnostic Value of Insulin Autoantibodies for Latent Autoimmune Diabetes in Adults

[Cross-Sectional Study of the Relation Between Carboxypeptidase-H Antibody and Islet Beta Cell Function in Patients with Latent Autoimmune Diabetes in Adults].

The Diagnostic Value of Protein Tyrosine Phosphatase Antibody for Latent Autoimmune Diabetes in Adults

Diagnostic Value of Carboxypeptidase-H Autoantibodies in Detecting Latent Autoimmune Diabetes in Adults

[Clinical Features of Non-Alcoholic Fatty Liver Disease and Its Relationship with Serum C-peptide Levels in Patients with Latent Autoimmune Diabetes in Adults].

Glutamic Acid Decarboxylase Autoantibody Detection by Electrochemiluminescence Assay Identifies Latent Autoimmune Diabetes in Adults with Poor Islet Function.

Urine C?peptide concentration and urine C?peptide creatinine ratio could predict residual β?cell function in type 1 diabetes mellitus with undetectable fasting serum C?peptide

Lipid Accumulation Product Combined With Urine Glucose Excretion Improves the Efficiency of Diabetes Screening in Chinese Adults

Carboxypeptidase-H antibody assay for the diagnosis of latent autoimmune diabetes in adults

Optimal Cutoff Point of Glutamate Decarboxylase Antibody Titers in Differentiating Two Subtypes of Adult-Onset Latent Autoimmune Diabetes

Frequency, Immunogenetics, and Clinical Characteristics of Latent Autoimmune Diabetes in China (LADA China Study)